How to use Technologies searched

A search for a company looking for a cancer, preclinical stage, synthetic opportunity would use the selection "Biomedicine, Diagnostics" in 'Sector', 'Cancerous, neoplasmatic' in 'Disease Category', 'Drugs, Small Molecule' in 'Technology' and 'Preclinical' in 'Development Stage'.

Selection of 'Enabling Technology, Platform technology' in 'Sector' will identify all kinds of searches for technologies that can be used in more areas of life sciences than pharmaceuticals only.

Each search profile gives the name or a short description of the company behind the search, and a link allowing to contact your potential licensee.

Registered users can create non-public notifications profiles which will inform them about new Technologies Searched entries fitting their expertise as specified. In addition these profiles allow them to filter the available information more comfortably.

Name

Vertex is seeking partnerships

Organization name

Vertex business development

Profile

Vertex Pharmaceuticals Incorporated is a global biotechnology company committed to the discovery and development of breakthrough small molecule drugs for serious diseases. The Company´s strategy is to commercialize its products both independently and in collaboration with major pharmaceutical companies.

Vertex´s product pipeline is focused on:

  • viral diseases
  • inflammation
  • autoimmune diseases
  • cancer
  • pain
  • bacterial infection.

Vertex co-discovered the HIV protease inhibitor, Lexiva, with GlaxoSmithKline. In addition to forging new collaborations, Vertex is actively pursuing in-licensing and acquisition opportunities that could serve to accelerate the Company´s business strategy.

Vertex´s in-licensing efforts are focused on later-stage products (Phase II or III) in a wide range of therapeutic areas, as well as earlier-stage products (e.g. preclinical or Phase I) in specific therapeutic areas that are core to the Company´s commercial goals.

Vertex is focused on structuring in-licensing deals and acquisitions that meet the strategic objectives of both parties and build shareholder value. With a strong cash position and a world-class research and development team, Vertex possesses the resources and commitment to ensure the success of in-licensed products.

To view the contact information, attachments and url of this profile you have to login into your account or register a new account: Login Register

Your feedback

Please click here to log in to view the complete profile.

 
 

latest entries